中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
The Effect of First-in-Class Small Molecule RhoA Inhibitor, HL07, on the Phenylephrine-induced Artery Contraction

文献类型:期刊论文

作者Zhang, Yan1; Deng, Jing3; Ma, Sheng1; Xue, Lin1; Zhu, Jin3; Zhu, Wei-liang2; Jiang, Hua-liang2,3; Li, Jian3; Miao, Li-yan1
刊名CURRENT PHARMACEUTICAL DESIGN
出版日期2012-09
卷号18期号:27页码:4258-4264
关键词RhoA/Rho-kinase pathway HL07 RhoA activation vasodilation binding affinities
ISSN号1381-6128
DOI10.2174/138161212802430387
文献子类Review
英文摘要The RhoA/ROCK inhibitors have emerged as a new promising treatment for cardiovascular diseases. Recently, we first reported a series of first-in-class small molecular RhoA inhibitors and a chemical compound named HL07 showed high RhoA inhibition activities. In this study, we aimed to explore the pharmacological effect and possible mechanism of HL07 on agonists-induced vasoconstriction. Results showed that 1) in rat thoracic aorta (TA) rings, HL07(0 similar to 180 mu mol/L) effectively inhibited phenylephrine (PE)-induced contraction in concentration-dependent manner, whereas the half maximal inhibitory concentration (IC50) being 156.93 mu mol/L, while it produced weak inhibition on high-K+ -induced contraction. Furthermore, in the presence of nifedipine and thapsigargin (Nif/TSG), HL07 had a comparable degree of inhibition on PE-induced contraction with IC50=149.52 mu mol/L; especially at the concentration (0 similar to 150 mu mol/L), the inhibition was greater than the inhibition in absence of Nif/TSG (P<0.01). In addition, HL07 displayed greater inhibition on pulmonary artery (PA) rings (IC50=134.97 mu mol/L) than on TA rings. 2) HL07 potently blocked RhoA activation stimulated by PE in concentration-dependent manner in human cerebrovascular smooth muscle cells (HBVSMCs), when HL07 at 10, 2, 0.25 mu mol/L, the corresponding inhibition rates were 64 +/- 5%, 42 +/- 7%, 31 +/- 5%, respectively; and at the same concentrations, HL07 had no significant effect on RhoA mRNA level. 3) In HBVSMCs, RhoA activity was increased by pre-incubating with GNP, but HL07 showed inhibitory effect on this tendency. These results indicate that HL07 produces significant inhibitory effects on PE-induced vascular smooth muscle contraction. The inhibitory effects of HL07 were mainly contributed to its inhibition on RhoA/Rho-kinase pathway through blocking RhoA activation, and the binding affinities of HL07 for RhoA preference over the GNP might be responsible for the inhibition of HL07 on RhoA activity.
WOS关键词INDUCED CA2+ SENSITIZATION ; C3 EXOENZYME ; KINASE ; PULMONARY ; RAT ; Y-27632
资助项目National Natural Science Foundation of China[21002028] ; National Natural Science Foundation of China[20902022] ; National S&T Major Project, China[2011ZX09102-005-02] ; Natural Science Foundation of Jiangsu Province[BK2008172] ; Shanghai Committee of Science and Technology[11DZ2260600] ; Fundamental Research Funds for the Central Universities[00000000]
WOS研究方向Pharmacology & Pharmacy
语种英语
WOS记录号WOS:000307871200018
出版者BENTHAM SCIENCE PUBL LTD
源URL[http://119.78.100.183/handle/2S10ELR8/277977]  
专题药物发现与设计中心
通讯作者Miao, Li-yan
作者单位1.Soochow Univ, Affiliated Hosp 1, Dept Clin Pharmacol Res Lab, Suzhou 215006, Peoples R China;
2.Chinese Acad Sci, Shanghai Inst Mat Med, Drug Discovery & Design Ctr, Shanghai 201203, Peoples R China
3.E China Univ Sci & Technol, Sch Pharm, Shanghai Key Lab New Drug Design, Shanghai 200237, Peoples R China;
推荐引用方式
GB/T 7714
Zhang, Yan,Deng, Jing,Ma, Sheng,et al. The Effect of First-in-Class Small Molecule RhoA Inhibitor, HL07, on the Phenylephrine-induced Artery Contraction[J]. CURRENT PHARMACEUTICAL DESIGN,2012,18(27):4258-4264.
APA Zhang, Yan.,Deng, Jing.,Ma, Sheng.,Xue, Lin.,Zhu, Jin.,...&Miao, Li-yan.(2012).The Effect of First-in-Class Small Molecule RhoA Inhibitor, HL07, on the Phenylephrine-induced Artery Contraction.CURRENT PHARMACEUTICAL DESIGN,18(27),4258-4264.
MLA Zhang, Yan,et al."The Effect of First-in-Class Small Molecule RhoA Inhibitor, HL07, on the Phenylephrine-induced Artery Contraction".CURRENT PHARMACEUTICAL DESIGN 18.27(2012):4258-4264.

入库方式: OAI收割

来源:上海药物研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。